Tovorafenib
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Recent Advances in the Classification and Treatment of Pediatric Gliomas
Journal: No shinkei geka. Neurological surgery
Published: August 16, 2026
Latest Classification and Management of Circumscribed Astrocytic Gliomas
Journal: No shinkei geka. Neurological surgery
Published: August 16, 2026
Practical management of BRAF inhibitors in glioma: toxicity and resistance.
Journal: CNS oncology
Published: August 03, 2026
Intratumoral and intracranial hemorrhage associated with MAPK-pathway targeted therapy: a systematic review and mechanistic synthesis.
Journal: Journal of neuro-oncology
Published: June 23, 2026
Access in all areas? A round-up of developments in market access and health technology assessment: first Joint Clinical Assessment report released.
Journal: Journal of comparative effectiveness research
Published: June 17, 2026
Incidence and predictors of hemorrhage in pediatric low-grade glioma.
Journal: Journal of neuro-oncology
Published: May 29, 2026
Class-level DILI saturation and hERG-driven risk stratification among 2024-2025 FDA-approved kinase inhibitors: an in silico multi-platform safety analysis.
Journal: Investigational new drugs
Published: March 16, 2026
Rebound regrowth phenomenon in patients with pediatric low-grade gliomas treated with MAPK inhibitors - a systematic review.
Journal: Oncology reviews
Published: February 23, 2026
Clinical experience with tovorafenib in adults with treatment-refractory high- and low-grade gliomas.
Journal: Neuro-oncology practice
Published: December 29, 2025
Emerging Targeted Therapies and Ongoing Clinical Trials in Pediatric Brain Tumors
Journal: No shinkei geka. Neurological surgery
Published: December 09, 2025
Rare gliomas: standard treatment approaches and new target therapies.
Journal: Current opinion in neurology
Published: September 24, 2025
Last Updated: 09/26/2026